Weaver Consulting Group Danaher Corp Transaction History

Weaver Consulting Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$212.5 - $245.46 $108,162 - $124,939	-509 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$177.16 - $215.33 $6,200 - $7,536	-35 Reduced 6.43%	509 $110,000
Q2 2020 Jul 24, 2020	BUY	$128.7 - $176.83 $38,095 - $52,341	296 Added 119.35%	544 $96,000
Q1 2020 Apr 28, 2020	BUY	$121.39 - $169.05 $4,248 - $5,916	35 Added 16.43%	248 $34,000
Q4 2019 Jan 31, 2020	BUY	$133.47 - $153.48 $10,010 - $11,511	75 Added 54.35%	213 $31,000
Q1 2019 Jun 19, 2019	BUY	$97.62 - $132.29 $13,471 - $18,256	138 New	138 $19,000

2,511

540M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $167B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

Stay updated on Weaver Consulting Group with notifications on news.